Valuation dashboard for HeartSciences Inc. (HSCS) with P/E N/A, P/B 53.02, EV/EBITDA 195.51 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process.
Analysis Summary
HeartSciences Inc. reported revenue of $4319 in the most recent fiscal year, growing at a 5-year CAGR of -29.9%.
Trailing-twelve-month margins: gross margin -29.8%, operating margin -1947.9%, net margin -2116.7%.
At the current price of $3.79, HSCS has negative trailing earnings (P/E not meaningful) and an ROE of -358.44%. Market capitalisation stands at $8M.
Balance sheet quality for HSCS: current ratio of 0.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 53.02 |
| EV / EBITDA | 195.51 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| HSCS | HeartSciences Inc. | $8M | 53.02 | -358.4% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $3.79 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -358.44% |
| Return on Invested Capital | -202.10% |
| Return on Assets | -173.71% |
| Gross Margin | -2982.10% |
| Operating Margin | -194787.38% |
| Net Margin | -211666.47% |
Related companies: AMIX · BCLI · BMRA · GBS · IBO · MTNB · MYNZ
Explore sector: Healthcare · Medical - Devices
More sections of HSCS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks